Standout Papers

Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression... 2005 2026 2012 2019 720
  1. Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer (2005)
    Yuichiro Ohigashi, Masayuki Sho et al. Clinical Cancer Research
  2. Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer (2007)
    Takeo Nomi, Masayuki Sho et al. Clinical Cancer Research

Immediate Impact

73 by Nobel laureates 16 from Science/Nature 161 standout
Sub-graph 1 of 18

Citing Papers

PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
The biology and management of non-small cell lung cancer
2018 StandoutNature
31 intermediate papers

Works of Kaoru Hamada being referenced

Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer
2007 Standout
Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer
2005 Standout

Author Peers

Author Last Decade Papers Cites
Kaoru Hamada 510 258 1277 914 54 2.3k
Jay S. Fine 589 595 789 1183 77 3.4k
Giancarlo Marone 440 737 663 1425 59 3.1k
Hirohisa Yoshizawa 1194 485 1710 946 84 3.4k
Amit A. Lugade 483 96 1366 1318 42 2.6k
Craig D. Wegner 542 931 689 1109 55 3.3k
R. Thompson 284 147 627 832 69 3.0k
Valérie Lecureur 375 198 1253 669 71 3.5k
John J. Rinehart 457 130 975 560 67 2.8k
Dong‐Sup Lee 396 420 540 631 70 2.6k
Parviz Lalezari 338 480 479 928 81 2.8k

All Works

Loading papers...

Rankless by CCL
2026